A Historical Cohort Study on the Efficacy of Glucocorticoids and Riboflavin Among Patients with Late-onset Multiple Acyl-CoA Dehydrogenase Deficiency

A Historical Cohort Study on the Efficacy of Glucocorticoids and Riboflavin Among Patients with Late-onset Multiple Acyl-CoA Dehydrogenase Deficiency

Background: Late-onset multiple acyl-CoA dehydrogenase deficiency (MADD) is the most common type of lipid storage myopathies in China. Most patients with late-onset MADD are well responsive to riboflavin. Up to now, these patients are often treated with glucocorticoids as the first-line drug because...

Full description

Bibliographic Details
Main Authors: Xin-Yi Liu, Zhi-Qiang Wang, Dan-Ni Wang, Min-Ting Lin, Ning Wang
Format: Article
Language:English
Published: Wolters Kluwer 2016-01-01
Series:Chinese Medical Journal
Subjects:
Glucocorticoids; Historical Cohort Study; Late-onset Multiple Acyl-CoA Dehydrogenase Deficiency; Lipid Storage Myopathy; Riboflavin
Online Access:http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=2;spage=142;epage=146;aulast=Liu

Internet

http://www.cmj.org/article.asp?issn=0366-6999;year=2016;volume=129;issue=2;spage=142;epage=146;aulast=Liu

Similar Items